GEOPOLITICS | US Opens Section 301 Probe Into Germany Over Pharmaceuticals

The US has started a Section 301 tariff investigation into Germany over what it called “persistent underpayment for innovative pharmaceutical products,” setting the stage for possible retaliatory levies on German goods. According to Bloomberg, the probe could lead to tariffs in response to the US allegations.